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Abstract
Multidrug resistance, which is acquired by both Gram-positive and Gram-negative bacteria, causes infections that are
associated with significant morbidity and mortality in many clinical settings around the world. Because of the rapidly
increasing incidence of pathogens that have become resistant to all or nearly all available antibiotics, there is a need for a
new generation of antimicrobials with a broad therapeutic range for specific applications against infections. Aedesin is a
cecropin-like anti-microbial peptide that was recently isolated from dengue virus-infected salivary glands of the Aedes
aegypti mosquito. In the present study, we have refined the analysis of its structural characteristics and have determined its
antimicrobial effects against a large panel of multidrug resistant bacterial strains, directly isolated from infected patients.
Based the results from nuclear magnetic resonance spectroscopy analysis, Aedesin has a helix-bend-helix structure typical
for a member of the family of a-helix anti-microbial peptides. Aedesin efficiently killed Gram-negative bacterial strains that
display the most worrisome resistance mechanisms encountered in the clinic, including resistance to carbapenems,
aminoglycosides, cephalosporins, 4th generation fluoroquinolones, folate inhibitors and monobactams. In contrast, Gram-
positive strains were insensitive to the lytic effects of the peptide. The anti-bacterial activity of Aedesin was found to be salt-
resistant, indicating that it is active under physiological conditions encountered in body fluids characterized by ionic salt
concentrations. In conclusion, because of its strong lytic activity against multidrug resistant Gram-negative bacterial strains
displaying all types of clinically relevant resistance mechanisms known today, Aedesin might be an interesting candidate for
the development of alternative treatment for infections caused by these types of bacteria.
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Introduction
Antibiotics have saved millions of lives worldwide by signifi-
cantly decreasing the mortality associated with infectious diseases.
However, these drugs are losing their effectiveness because of
increasing antimicrobial resistance, as their massive and repetitive
use in human and veterinary medicine has resulted in the
emergence of multidrug-resistant (MDR) strains of bacteria that
has become a serious global problem without any signs of abating.
The propensity of microbes to develop multidrug-resistance is a
natural trait following billions of years of evolution. Indeed,
widespread resistance against several types of modern synthetic
antibiotics has been discovered among bacterial strains that had
been geologically isolated from the surface of the earth for more
than 4 millions years [1], demonstrating that mechanisms of
antibiotic modification and inactivation are part of the highly
specific evolutionary adaptations of these microorganisms to evade
the cytotoxic action of antibiotics, even those they have yet to
encounter.
Particularly worrisome is the emergence of methicillin-resistant
Staphylococcus aureus (MRSA) and Enterococcus faecium, glyco-
peptide-resistant Enterococcus (GRE), as well as MDR Gram-
negative enterobacteria, in particular Escherichia coli, Klebsiella
pneumonia, Acinetobacter baumanii and Pseudomonas aeruginosa,
that, because of their production of broad-spectrum b-lactamases,
i.e. AmpC cephalosporinase overproduction and extended spec-
trum b-lactamase, have become resistant to the third generation of
cephalosporins [2]. The more recent emergence and expansion of
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the so-called carbapenemases determining resistance to carbape-
nems, a class of antibiotics of last resort for many bacterial
infections, is also a cause of concern since these enzymes are
presently found in the four known classes of b-lactamases (class A,
B, C and D) and are determined by genes frequently harbored on
highly transferable plasmids, in particular those coding for the
carbapenemases KPC (class A), VIM and NDM (class B), and
OXA-48 (class D) (see Table S1 for the corresponding resistance
profiles). As resistance towards antibiotics becomes more common,
there is an increased need for alternative treatments. However,
novel antibiotics are not being developed at anywhere near the
pace necessary to keep ahead of the natural ability of bacteria to
evolve and defend themselves against antibiotics and, in addition,
there has been a continued decline in the number of newly
approved drugs [3]. Therefore, in addition to better management
of antibiotic use, there is an urgent need for the development of
novel therapeutic approaches to treat infections with MDR
bacterial strains.
Ubiquitous in nature, antimicrobial peptides (AMP) are a
unique and diverse group of molecules that were initially identified
in insects and that form an important component of the innate
immune system in all living organisms [4,5]. AMP typically have
broad spectrum activity against pathogenic bacteria and fungi,
with various modes of action that may differ among bacterial
species. Based on structure-function relationship, these peptides
with a length between 12 and 50 amino acids can be divided in
three classes based on their secondary structure: a-helical peptides,
b sheet peptides - or mixed structures - and so-called extended
peptides that do not fold into regular secondary structure elements
and that often contain high proportions of certain amino acids,
specifically Arg, Trp or Pro residues [6]. Most AMP carry a
cationic charge that promotes selective interaction with negatively
charged bacterial membranes, rather than zwitterionic mamma-
lian cell surfaces. In addition, they contain amphipathic domains
which facilitate their interaction with fatty acyl acids, thereby
enabling them to associate with membranes, which is a definite
property of these peptides. Many linear AMP are unstructured in
aqueous solution and require a membranous environment to
adopt such a stable, amphipathic, conformation. As most bacterial
surfaces are anionic, the initial contact between the peptide and
the target organism is electrostatic. Their amino acid composition,
amphipathicity, cationic charge and size allow the AMP to attach
to and insert into membrane bilayers to form pores by ‘barrel-
stave’, ‘carpet’ or ‘toroidal-pore’ mechanisms [7]. In contrast to
many conventional antibiotics, AMP appear to be bactericidal [8]
instead of bacteriostatic, although in many cases, the exact
mechanism of killing is not known [7]. Because of their particular
mode of action, the antimicrobial properties of AMP have raised
clinical attention and research interest over the past years [9].
Importantly, natural AMP have co-evolved with bacterial strains
and their ability to permeabilize cytoplasmic membranes is less
prone to the development of resistance, such as changes in the
molecular charge of cell surface proteins or proteolytic cleavage
following the release of extracellular proteases. The latter processes
will not only take much longer periods of time, as compared to
resistance induced by conventional antibiotics, but also have the
potential to compromise cell wall integrity and are therefore
detrimental to bacterial survival.
Recently, we have reported the identification of a cecropin-like
AMP from the dengue virus-infected salivary glands of Aedes
aegypti [10] for which the term Aedesin is coined. The chemically
synthesized form of this peptide with a length of 36 amino acid
residues was found to possess antibacterial activity against E. coli.
In the present study, we have refined the analysis of Aedesin
structural characteristics using nuclear magnetic resonance spec-
troscopy analysis and have furthermore determined its antimicro-
bial effects against a large panel of multidrug resistant clinical
bacterial isolates and susceptible control reference strains.
Materials and Methods
Peptide synthesis
The identification of the cecropin-like peptide AAEL000598
peptide was recently described [10]. The peptide, with the
following sequence 26GGLKKLGKKLEGAGKRVFKASEKALP-
VVVGIKAIGK61 and referred to as Aedesin in the present study,
was chemically synthesized by Proteogenix (Schiltigheim, France)
using FMOC (N-(9 fluorenyl)methoxycarbonyl) chemistry. The
peptide is numbered starting from 26G till K61, the first 25 residues
not being included as they correspond to the leader sequence. In
addition, a peptide of identical amino acid composition, but with a
scrambled sequence (VAKGLIKGVKAKGELPAKGVFKGLKE-
SIGKRAVLKG) and referred to as VG26-61, was synthesized and
used as a negative control. The peptides were purified by reverse-
phase preparative HPLC on a C18 column (206250 mm; Shim-
pack) using an appropriate 0-90% water/acetonitrile gradient in
the presence of 0.05% trifluoroacetic acid. The purity of both
peptides was checked by mass spectrometry and was more than
95% (data not shown). The molecular mass of both peptides was
determined by matrix-assisted laser desorption ionization time-of-
flight mass spectrometer (Axima-CFR Plus; Shimadzu). The
concentration of the peptides was determined using an UV
spectrometer.
Nuclear magnetic resonance spectroscopy
The NMR sample was prepared by dissolving the Aedesin in a
mixture of 50% PBS pH 7.4/50% TFE at a concentration of
784 mM in a 3 mm tube. TFE-d3 was purchased from Euriso-top.
For the experiment in D2O the sample was lyophilized and
dissolved in a mixture of 50% D2O/50% TFE. Spectra were
acquired on 700 MHz Avance Bruker spectrometer equipped with
triple-resonance (1H, 15N, 13C) z-gradient cryo-probe. Experi-
ments were recorded using the Bruker TOPSPIN pulse sequence
library (v.2.1). For all experiments, the recycling delay was 1.5 sec.
2D-Nuclear Overhauser effect spectroscopy (NOESY) experiment
with excitation sculpting water suppression were acquired at 283K
and 302K, with 48 scans and 2048 (t2)6512 (t1) data size, and
10.2 ppm spectral width. The NOE mixing time was 200 msec.
2D- Total correlation spectroscopy (TOCSY) experiments with
excitation sculpting water suppression was acquired at 283K with
32 scans and 2048 (t2)6512 (t1) data size, and 10.2 ppm spectral
width. The mixing time was 60 msec. 2D-15N-1H HSQC with
binomial water suppression was acquired at 283K with 1024 scans
and 1500 (t2)6128 (t1) data size, and 10.2 ppm for the 1H and 40
ppm for the 15N spectral width. 2D-13C-1H HSQC was acquired
with a D2O/TFE (50/50%) sample at 283K with 512 scans and
2048 (t2)6182 (t1) data size, and 10.2 ppm for the 1H and 80 ppm
for the 13C spectral width. All spectra are referenced to the
internal reference DSS (4,4-dimethyl-4-silapentane-1-sulfonic ac-
id) [11].
NMR data were processed using Topspin software and were
analyzed using strip-plots. Side chain assignments were carried out
using 2D-NOESY and 2D-TOCSY experiments with D2O/TFE
samples. The side chain 1H resonances were assigned, with the
exception of Hd-He of Lys residues, the Hf of Phe43 and the Hc
of Leu50. The NH of the first Gly residue remained unassigned.
15N assignments were derived from the 2D-15N-1H HSQC,
however, due to NH superimposition, the 15N resonances of
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Glu36, Ala38, Val42, Phe43, Ser46, Val54 and Ile56 were not
assigned. 13C assignments were derived from the 2D-13C-1H
HSQC but the Ca of residues Gly26, Leu31, Lys34, Leu35, Lys40
and Ile56, and the Cb of residues Lys29, Lys30, Lys33, Lys34,
Lys40 and Lys44 could not be assigned.
Structure calculation
Structure calculations were carried out by using the programs
CYANA and CNS. From the NOESY at 283K, NOEs were
classified from strong, medium and weak, corresponding to 2.8,
3.6 and 4.4 A˚ upper bound constraints, respectively. Structure
calculations were performed with CYANA (v. 2.1) [12] using the
372 distance restraints from 2D- NOESY experiments. The NH,
Ha, 15N, 13Ca and 13Cb chemical shifts were converted into 52
W/Y dihedral angle constraints using TALOS+ (v. 1.2).
CYANA was used to calculate 100 structures, of which the 20
conformers with the lowest target function were refined by CNS (v.
1.2) [13] using 1000 steps of torsion angle dynamics at 250 K and
1000 steps of slow cooling to 100K, followed by 200 steps of
Powell minimization. The final 20 conformers were selected with
the lowest NOE and dihedral angle violations, and are the
structures discussed herein and deposited (PDBs). The final 20
structures contained no NOE violations greater than 0.3 A˚ and no
dihedral angle constraint violations greater than 2u. Structures
were validated using PROCHECK [14]. The structure of Aedesin
has been deposited at the Protein Data Bank (www.rcsb.org),
under the entry assigned accession code: 2MMM.
Circular Dichroism (CD) analysis
CD spectroscopy was used to investigate the secondary structure
adopted by Aedesin in membrane-mimetic environments (1, 5 and
100 mM sodium dodecyl sulfate (SDS)). CD analysis was
performed using a Chirascan Circular Dichroism Spectro-
phometer (Applied photophysics, Surrey, United Kingdom) with
a polarized selected quartz cuve of 0,5 mm path length at 20uC.
Wavelength from 180 to 260 were measured with a step of 0,5 nm
and a bandwith of 2 nm. CD spectra were generated from an
average of five scans of each sample. The peptide concentration
was 45 mM in phosphate buffer (pH 7.4) containing 137 mM NaF
for all experiments. Percentage of helicity was calculated using
CONTIN Software (http://dichroweb.cryst.bbk.ac.uk).
Bacterial strains
Five susceptible reference (E. coli ATCC 25922, A. baumannii
ATCC 17978, P. aeruginosa ATCC 27853, E. faecalis ATCC
700802 and S. aureus ATCC 25923) and nineteen human clinical
multidrug-resistant (MDR) or extensively drug-resistant (XDR)
[15] strains commonly involved in human infections were used for
MIC determination for Aedesin (Table S1). Fifteen and four
clinical MDR/XDR isolates were collected at the Department of
Bacteriology of the Montpellier University Hospital (DBUH) and
Paris Salpeˆtrie`re University hospital respectively from 2012 to
2014. Among these bacteria, we have selected three A. baumannii,
three P. aeruginosa, five E. coli, two K. pneumonia, three
S. aureus and three E. faecium isolates. According to routine
procedures, species identification was performed using matrix-
assisted laser desorption ionization–time of flight (MALDI-TOF)
mass spectrometry (MS) system methods (Bruker Biotyper) and the
phenotypes of resistance to antibiotics were determined by using the
disk (Bio-Rad, Marne-la-Coquette, France) diffusion method
according to guidelines edited by the European Committee on
Antimicrobial Susceptibility Testing (http://www.eucast.org). Zone
diameter results were interpreted based on breakpoints established
for each bacteria species by the Antibiogram Committee of the
French Society of Microbiology (http://www.sfm-microbiologie.
org). The definition of MDR, XDR and pandrug-resistant (PDR)
came from international consensus Multidrug-resistant, extensively
drug-resistant and pandrug-resistant bacteria: an international
expert proposal for interim standard definitions for acquired
resistance [15].
Antibacterial activity
The antimicrobial activity of antibiotics, Aedesin and the
scrambled control peptide VG26-61 against bacterial strains was
determined by measuring the minimal inhibitory concentration
(MIC) which represents the lowest concentration of drug or
peptide that inhibits bacterial growth, using a broth microdilution
method in 96-well plates (Microtest Tissue Culture plate,
FALCON). In brief, pre-cultures were prepared by inoculation
of 3 mL Mueller-Hinton (MH) browth and incubation at 37uC
overnight under shaking. The pre-cultures were diluted to 1/100
in 3 mL MH and incubated for an additional 4 h at 37uC. The
first column of the plate was a negative growth control, containing
only 0.1 mL of MH. Columns 2 and 11 contained each 0.05 mL
of peptide with a final concentration range of 0.0625 to 32 mg/
mL, obtained by successive dilution of the peptide in the MH
medium. The diluted peptides were prepared in the plate at
concentrations 2 times higher than the desired final concentrations
followed by the addition of the same volume of inoculum (total
volume 0.1 mL/well). Inocula were prepared to obtain a final OD
of 0.001 at a wavelength of 600 nm (Infinite F200 PRO, TECAN,
Lyon, France), corresponding to 106 CFU/mL. The last column
of the plate was a positive growth control (without peptide),
containing 0.05 mL of inoculum plus 0.05 mL of MH. The plates
were incubated at 37uC for 22–24 h prior to the determination of
the MIC, corresponding to the lowest concentration of drug or
peptide necessary for preventing bacterial growth as visually
observed (no growth viewed from the back of the plate against a
dark background illuminated with reflected light) and confirmed
by OD measurement at 600 nm in a plate reader (Infinite F200
PRO, TECAN).
Gentamicin and tobramycin were used for the susceptibility
testing with Escherichia coli ATCC 25922 strain as an internal
control. The breakpoints were determined using the European
Committee on Antimicrobial Susceptibility Testing (EUCAST).
Bactericidal activity
Non-treated bacteria were cultured to mid-log phase at 37uC in
MH medium, spun for 10 minutes at 1000 g, resuspended in MH
medium and diluted to an OD at 600 nm of 0.30 corresponding to
108 CFU/ml. The bacteria were then grown for an additional
13 h in the absence or the presence of Aedesin followed by the
determination of the OD at 600 nm.
Analysis of the results
To evaluate the reproducibility of the assay, independent tests
were performed using the susceptible referent strains (three tests)
and the 19 clinical isolates (three tests). The reproducibility value
was defined as the percentage of strains which gave the same
MIC61 log2 dilution at each test. The lecture of the MIC was
performed by two independent operators.
Transmission Electron Microscopy
Treated bacterial pellets were washed in phosphate buffered
saline, fixed overnight in 2.5% glutaraldehyde (Electron Micros-
copy Sciences, Hatfield, US) and in 0.1 M sodium phosphate
buffer at 4uC. Cells were post-fixed in 1% osmic acid (Electron
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Microscopy Sciences) for 1 hour at 4uC and with 0.5% tannic acid
(Merck-Millipore, Darmstad, Germany) at 4uC for 30 min.
Bacteria were dehydrated in a graded series of ethanol solutions
(70/90/100%) for 30 min, embedded into resin and left to
polymerize at ambient temperature for 1 h. Resins were sectioned
by cutting an 80 nm film at 25uC using an ultramicrotome
Ultracut Reichert (Leica Microsystemes SAS, Nanterre, France).
Imaging was carried out using a Hitachi H1700 transmission
electron microscope (Hitachi, Verrie`res-le-Buisson, France).
Scanning Electron Microscopy
The morphological changes of bacterial cells, either untreated
or incubated with Aedesin or the scrambled control peptide
VG26-61, were determined by Scanning Electron Microscopy.
Bacteria were spun at 300 g for 30 min after which the pellets
were washed three times with phosphate buffered saline and
deposited in 12 well plates. Samples were observed using a Hitachi
S4000 electron microscope.
Results
NMR structure of GK 26-61
Both NOESY and TOCSY spectra were collected for Aedesin
at 283K, pH 7.4 in 50% TFE. The spin systems were identified
based on the TOCSY spectrum with a mixing time of 60 ms and
sequential assignments were obtained using the NOESY spectrum
Figure 1. NOESY spectrum and NOE connectivities of Aedisine. (A) 15N-1H HSQC spectrum of Aedesin (G21- K61) at 50% TFE, pH 7.4 and 283K
(mixing time, 200 ms). * indicates side chain NeH. (B) Schematic representation of NOE connectivities for Aedesin in 50% TFE. The intensity of the
connectivity is reflected by the thickness of the bars.
doi:10.1371/journal.pone.0105441.g001
Figure 2. Calculated structures of Aedesin. (A) Superimposition of the 20 structures of Aedesin using backbone atoms. (B,C) the structures were
aligned by two sections which are helix 1 from residues Lys30 to Lys48, and helix 2 from residues Val52 to Ile59, respectively.
doi:10.1371/journal.pone.0105441.g002
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with a mixing time of 200 ms. Figure 1A shows the assignments of
the 15N-1H cross peaks for GK 26-61. The 15N resonances of
Glu36, Ala38, Val42, Phe43, Ser46, Val54 and Ile56 could not be
unambiguously assigned and are represented according to
standard amino-acid 15N chemical shifts. The (i, i+3) NOE
connectivities denote an a-helical structure. Two stretches of
daN(i, i+4) NOE connectivities indicate the presence of regular a-
helical conformation in the Leu28-Lys40 and Pro51-Lys61 regions.
A summary for the sequential and medium range distance
constraints for Aedesin in 50% TFE is shown in Figure 1B.
The solution structure of Aedesin was calculated using 372
NOE constraints derived from the NOESY spectrum at 283K.
Dihedral angle constraints were obtained from NH, Ha, 15N,
13Ca and 13Ca chemical shifts data converted into 52 W/Y
dihedral angle constraints using TALOS+. The analysis of the 20
overlapping structures of Aedesin (Figure 2) shows that the helical
conformation is roughly continuous with a bent at residues 49-51,
whereas those of the 20 final structures resulted in a Root-mean-
square deviation (RMSD) of 0.846 A˚ for the backbone atoms and
1.597 A˚ for the heavy atoms. The structure of Aedesin is depicted
as a helix-bent-helix structure with good RMSD statistics for the
N-terminal helix (helix 1) and for the C-terminal helix (helix 2)
taken separately. Structural statistics and the root mean square
deviations for the 20 lowest energy structures of Aedesin are given
in Table 1. The Ramachandran plot computed by PROCHECK
shows that all the residues fall in the allowed conformational
regions. Three amino acids, namely Ala-49, Leu-50 and Pro-51,
are in the helical region of the Ramachandran plot. This also
supports the NOE data obtained for these residues with the
presence of daN(i, i+3) and dab(i, i+3) NOE connectivities. The
helical wheel diagram of Aedesin shows the amphipathic character
of the first and second a-helices, as well as the opposite localization
of their hydrophobic and positively charged residues, respectively
(Figure 3). Whereas helix 1 has a prevalence of hydrophilic
charged residues and a rather reduced hydrophobic side, the short
second helix has a hydrophobic surface that consists of two Val
Figure 3. Helical wheel diagrams of Aedesin. (A) N-terminal helix region (helix 1) from Lys30 to Lys48 and (B) C-terminal helix (helix 2) from Val52
to Ile59. The hydrophobic or charged residues are indicated in black letters within the white circles and white letters within the dark grey circles,
respectively. Other residues, including non-polar amino acids, are indicated in the light grey circles.
doi:10.1371/journal.pone.0105441.g003
Table 1. Summary of structural constraints and structure
statistics.
NOE constraints
Intraresidues (|i-j| = 0) 75
Sequential (|i-j| = 1) 142
Medium range (2#|i-j|#4) 155
Long range (|i-j|.4) 0
Dihedral angles 52
Structural Statistics (20 Structures)
NOE violations, number .0.3 A˚ 0
Dihedral angle violations .2u 0
RMSD for geometrical analysis
Bond lengths (A˚) 0.0026+/20.00013
Bond angles (degree) 0.4057+/20.0077
Improper (degree) 0.3294+/20.0151
RMSD from experimental constraints
Distance (A˚) 0.0293+/20.0011
Dihedral angle (degree) 0.1659+/20.0311
Mean total energy (kcal.mol-1) 83.82+/25.60
Atomic RMSD
Overall (26–61)
Backbone 0.846
Heavy atoms 1.597
Helix 1 (30–48)
Backbone 0.534
Heavy atoms 1.409
Helix 2 (52–59)
Backbone 0.047
Heavy atoms 0.658
doi:10.1371/journal.pone.0105441.t001
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and two Ile residues, indicating a stronger hydrophobic potential
than the first helix.
Circular dichroism measurements
To investigate the secondary structure of Aedesin in a
membrane-like environment, we analyzed the CD spectra of the
peptide dissolved under increasing concentrations of SDS leading
to the formation of micelles. As shown in Figure 4, the CD
spectrum of Aedesin exhibited double minimum bands at 208 and
222 nm which indicate that Aedesin adopted a well-defined a-
helical structure, already in the presence of 1 mM SDS, with a
total helix content of 30% which remained stable also at
concentrations of 5 and 100 mM SDS, respectively. In contrast,
in the absence of SDS, the peptide was unable to form an a-helical
structure.
Antimicrobial activity of Aedesin
The antimicrobial activity of the Aedesin was determined on a
comprehensive series of pathogenic, non-resistant, as well as MDR
or XDR, Gram-positive and Gram-negative, bacterial isolates,
commonly involved in human infections. The resistance pheno-
types of each of the MDR or XDR strains, including S. aureus,
E. faecalis, E. faecium, E. coli, P. aeruginosa, A. baumannii and
K. pneunomiae to different classes of antibiotics is recapitulated in
Table S1. In particular, the E. coli NMD1 and OXA48, as well as
the K. pneunomiae KPC and VIM strains were selected because of
the serious problems that they cause in the clinic, being resistant to
the latest generation of antibiotics. Aedesin displayed strong anti-
bacterial activity against all sixteen Gram-negative strains tested,
independent of their antibiogram, as demonstrated by the low
MIC values ranging between 1 and 4 (Table 2). In contrast, no
antibacterial effects of the peptide were observed against different
isolates of Gram-positive S. aureus, E. faecalis and E. faecium
strains showing MIC values over 32. The scrambled control
peptide VG26-61 was totally ineffective, irrespective of the
bacterial strain.
High salt concentrations are known to interfere with electro-
static contact between AMP and the negatively charged bacterial
membrane, thereby potentially inhibiting their anti-microbial
effects. To determine the activity of Aedesin in such an
environment, the peptide was tested for salt resistance in the
presence of either 150 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, or
a combination of these salts. Under these experimental conditions,
Aedesin still showed a strong antimicrobial effect against all Gram-
negative MDR strains, with MIC values between 1 and 2,
indicating that its mode of action is maintained in a high salt
environment (Table 3).
Aedesin has bactericidal activity
The bactericidal activity of Aedesin was determined against two
different MDR bacterial strains by measuring the viability
following culture in the presence of either the Aedesin or the
Figure 4. Circular dichroism of Aedesin in the presence of SDS micelles. CD spectra of the peptide were measured in phosphate buffer
containing 137 mM NaF at SDS concentrations of 0, 1, 5 and 100 mM.
doi:10.1371/journal.pone.0105441.g004
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VG26-61 control peptide. Following a 13 h culture of E. coli and
P. Aeruginosa in the presence of Aedesin at a concentration of
2 mg/mL, the OD600 diminished from 0.3560.04 at the onset of
the cultures to 0.1760.01 and 0.1160.01, respectively. In
contrast, culture of the bacteria in the presence of the VG26-61
did not have any effect on their growth, with OD600 values of
1.260.01 and 1.560.01, respectively, at the end of the cultures.
Effect of Aedesin treatment on the morphology of E. coli
E. coli treated with phosphate buffer only or with the scrambled
control peptide VG26-61 had an intact outer membrane and
displayed a regular cytoplasm, as shown by transmission electron
microscopy analysis (Figure 5A,B). However, exposure of the
bacteria to Aedesin resulted in strong aggregation and an
important alteration of their cell membrane (Figure 5C). The
strongly altered surface morphology of the bacteria treated with
Aedesin was even more evident following analysis by scanning
electron microscopy (Figure 5D–F).
Discussion
Infections caused by MDR bacterial strains, resistant to even the
latest class of antibiotics, have become a serious and worldwide
problem. This is the consequence of a variety of microbial
mechanisms, including production of enzymes that modify or
destroy the active components of the antibiotic (by far the most
prevalent mechanism), modification of the metabolic pathways
that are antibiotic targets, as well as reduction of drug
accumulation by rendering the bacterial cell wall impermeable
for the antibiotic or by increasing active efflux of antibiotics across
the cell surface [16]. Because of their particular mechanism of
action, which is associated with a decreased tendency to induce
bacterial resistance, AMP have gained considerable interest over
the past decade as a possible alternative means to combat
multidrug-resistance. In the present study, we have determined the
antimicrobial capacity of one such AMP, denominated Aedesin, a
cecropin-like peptide derived from the saliva of DENV-infected
Aedes aegypti mosquitos [10]. In insects, cecropins form a large
family of cationic a-helical peptides that are active mainly against
Gram-negative bacteria [17,18,19,20,21]. Indeed, similar to
CecropinA, Aedesin was found to be selective for Gram-negative
bacteria and to efficiently kill a wide variety of MDR bacterial
strains, including P. aeruginosa, A. baumannii, K. pneumoniae
and E. coli with MIC values between 1 and 2 mg/mL.
The antimicrobial activity of certain AMPs, such as human b-
defensins and the major human cationic host defense peptide LL-
37, is strongly antagonized in conditions characterized by high
ionic concentrations, which might preclude their therapeutic use
in serum or other bodily fluids. For example, human b–defensins,
as well as the major human cationic host defense peptide LL-37,
Table 2. Antimicrobial activities of Aedesin against MDR
bacterial strains.
Isolates MIC (mg/mL) of Aedesin MIC (mg/mL) of VG26-61
E. coli
ATCC 25922 2 (1–2) .32
EcESBL1 4 (2–4) .32
Ec2 4 (2–4) .32
EcESBL3 4 (2–4) .32
EcNMD1 2 .32
EcOXA48 2 .32
P. aeruginosa
ATCC 27853 4 (2–4) .32
Pa1 1 .32
Pa2 2 .32
Pat3 1 .32
A. baumannii
ATCC 17978 2 .32
Ab1 2 .32
Ab2 2 .32
Ab3 1 .32
K. pneumoniae
KpKPC 2 .32
KpVIM 1 .32
S. aureus
ATCC 25923 .32 .32
MRSA1 .32 .32
MRSA2 .32 .32
MRSA3 .32 .32
Enterococcus
ATCC 700802 .32 .32
EfmGRE1 .32 .32
EfmGRE2 .32 .32
EfmGRE3 .32 .32
doi:10.1371/journal.pone.0105441.t002
Table 3. Salt resistance of Aedesin.
Added salt Concentration (mM) E. coli P. aeruginosa
MIC (mg/mL) of Aedesin MIC (mg/mL) of VG26-61 MIC (mg/mL) of Aedesin MIC (mg/mL) of VG26-61
none - 1 .32 1–2 .32
NaCl 150 1 .32 1 .32
CaCl2 1 1 .32 1 .32
MgCl2 1 2 .32 2 .32
NaCl + 150 1 .32 1 .32
CaCl2 + 1
MgCl2 1
doi:10.1371/journal.pone.0105441.t003
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are rapidly inactivated in the NaCl concentrations present in the
airway surface liquid of cystic fibrosis patients [22], whereas
interactions between cationic peptides and the outer surface
component of Gram-negative bacteria are inhibited in the
presence of high concentrations of bivalent ions [23]. However,
the strong anti-bacterial activity of Aedesin was not affected by the
presence of NaCl, MgCl2, CaCl2, or a combination of these salts,
at concentrations similar to those present in human bodily fluids
[24], indicating that its killing mechanism is salt-resistant.
Moreover, Aedesin is not toxic for human cells, at any of the
concentrations used [10], further indicating that this AMP might
have potential therapeutic use in a physiological environment. It is
to be stressed however that peptides, and in particular AMP, have
poor in vivo stability, in particular when composed of L-amino
acids, and are readily disintegrated by proteolytic enzymes in
bodily fluids or recognized and processed by tissue-resident
antigen-presenting cells which limits their systemic therapeutic
use. Moreover, renal clearance limits the in vivo half-life of
peptides in the circulation to only a few hours [25]. These
considerations notwithstanding, several approaches that impede
proteolysis in serum conditions, while retaining the bactericidal
activity of the AMP, have been reported, such as substitution of L-
by D-amino acids, cyclization of the peptides, use of fluorinated
amino acids, beta peptides or conjugation of fatty acids [26].
Another strategy is the substitution of certain residues by unusual
amino acids. For example, the replacement of Arg residues within
the Oncocin-1 peptide by Orn [27] or Arg substitution within
cationic amphiphilic or cationic polypeptides by Aib and Agp
residues [28] were shown to confer protection to degradation and
improve serum stability. A detailed structure-function analysis of
Aedesin therefore needs to be carried out to determine, and
possibly ameliorate, the pharmacokinetics and bioavailability of
this peptide for systemic use.
The results from CD analysis of the peptide in the presence of
increasing concentrations of SDS showed that Aedesin readily
adopts a helical structure in a hydrophic environment. This
finding was confirmed and extended by the results from NMR
analysis demonstrating that Aedesin consists of two regular
amphipatic a-helices in the Lys30-Lys48 and Val52-Ile59 regions,
respectively, at the N- and C-terminal part of the peptide. The N-
terminal region contains a large stretch of positively charged
residues including six Lys residues. In contrast, the C-terminal
helix is clearly hydrophobic with two Ile and three Val residues,
separated by a single charged Lys. Although the presence of a
helix-hinge-helix is a common feature found in many cecropin
family members, this property does not guarantee its antibacterial
activity. For example, cecropin B1, although sharing a similar
conformation with Aedesin, has poor anti-microbial activity [29],
underscoring the correct composition and distribution of key
amino acid residues in Aedesin that are critical for this function.
Our results from scanning electron microscopic analysis show
that Aedesin strongly alters the bacterial morphology, indicating
that it exerts its lytic function by disrupting the bacterial outer
membrane of Gram-negative bacteria. Similar results have been
reported for Cecropins B, D [19], as well as Cecropin A. Indeed,
using lipid vesicles with varying phospholipid composition,
mimicking mammalian or microbial membranes, Cecropin A
was found to preferentially permeate microbial or fungal
membranes characterized by the presence of negatively charged
phospholipids, rather than zwitterionic phospholipid-containing
mammalian membranes [29]. In this respect, it is of note that
Aedesin also kills the parasite Leishmania donovani [10], which is
in agreement with previously published reports that demonstrate
the presence of high amounts of lipophosphoglycan molecules in
the membrane of this promastigote [30,31], thus forming a
protective anionic barrier shielding that is sensitive to cationic
molecules or ionizable phospholipid groups that cause destabili-
zation of the membrane [32].
Like other cecropins, Aedesin is ineffective against various
MDR S. aureus strains, thus corroborating the notion that the
cytoplasmic membranes of Gram-positive bacteria are inherently
more resistant to these cationic peptides, as compared to Gram-
Figure 5. Electron microscopic analysis of Aedesin-treated bacteria. E. coli were either untreated (A,D) or incubated with VG26-61 (B,E) or
Aedesin (C,F), respectively for 2 h at 37uC, prepared as indicated in Materials and Methods and analyzed by transmission (A–C) and scanning (D–F)
electron microscopy.
doi:10.1371/journal.pone.0105441.g005
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negative microorganisms [19]. Indeed, the interaction between the
peptide and the bacterial membrane is determined by the lipid
composition of the membrane, its surface charge density and by
the presence of an electrochemical potential across the membrane,
underscoring the difference between the membrane components,
resulting in their differential sensitivity to membrane permeabili-
zation by cationic peptides, between both groups of bacteria.
In conclusion, the results of this study show that the killing of
MDR bacterial strains by Aedesin is independent from most
mechanisms of bacterial resistance. Although it is unlikely, in its
present form, to be used to systemically treat MDR Gram-negative
bacterial infections, the topical use of this cationic AMP could be
envisaged. For example, polymyxin B and E, while toxic at clinical
doses for systemic use as anti-bacterial drugs, have been
successfully implemented in the treatment of cutaneous infections
caused by P. aeruginosa and A. baumannii [25], both strains that
are highly susceptible to the bactericidal effects of Aedesin, as
shown in the present study. Certain AMP have also been
formulated in artificial tear solutions, lens preservation fluid and
generic wound creams [33]. Of great interest is the application of
cationic peptides against biofilm-forming bacterial infections. In
particular, their application as nanofilms or other coating
materials for surgical devices, including catheters and medical
implants are currently under study [34]. Substitution experiments
to determine the essential amino acid residues involved in the lytic
function of this peptide, while trying to preserve or ameliorate its
stability are currently underway.
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